Pathophysiological Insights into Malarial Anaemia and Systemic Inflammation in Plasmodium falciparum and Plasmodium vivax Infections

Malaria-induced anaemia remains one of the most prevalent and debilitating complications of Plasmodium infection, particularly in endemic regions like Jharkhand. This study provides a detailed analysis of the pathophysiology underlying haematological disturbances in patients infected with Plasmodium falciparum and Plasmodium vivax. A total of 106 individuals—52 with P. vivax, 42 with P. falciparum, and 12 with mixed infection—were compared to 33 healthy controls matched for age, sex, and socioeconomic background. Comprehensive evaluation included haemoglobin (Hb), packed cell volume (PCV), erythrocyte sedimentation rate (ESR), blood sugar, serum bilirubin, serum creatinine, and blood urea.

The data revealed a significant reduction in Hb and PCV across all infection types: mean values of 10.56 g/dL and 28.42% in P. vivax, 9.58 g/dL and 30.74% in P. falciparum, and 9.46 g/dL and 27.42% in mixed infection, compared to 12.35 g/dL and 48.64% in healthy subjects. These reductions were statistically significant (P < 0.001) and consistent with malarial anaemia. The severity was more pronounced in P. falciparum cases, likely due to higher parasite burden, enhanced cytoadherence, and increased intravascular haemolysis. Elevated ESR—averaging 82.19 mm/h in P. vivax, 77.79 mm/h in P. falciparum, and 78.42 mm/h in mixed infection—was significantly higher than the control value of 11.4-tert-Amylphenol Metabolic Enzyme/Protease 64 mm/h (P < 0.001), indicating systemic inflammation. This increase correlates with cytokine release, immune activation, and acute-phase protein production during malaria infection. Notably, ESR showed a negative correlation with age in P. vivax infection (r = –0.319, P = 0.02), suggesting that younger individuals exhibit stronger inflammatory responses. Serum bilirubin levels were significantly elevated in both P. vivax (2.24 mg/dL) and P. falciparum (2.35 mg/dL) infections compared to controls (1.59 mg/dL), confirming ongoing haemolysis. Bilirubin elevation was more marked in P. falciparum, reflecting greater red blood cell destruction. Serum creatinine was also significantly higher in P. falciparum (1.36 mg/dL) and P. vivax (1.42 mg/dL) cases than in controls (1.25 mg/dL), pointing to early renal dysfunction. In contrast, creatinine was reduced in mixed infection (0.97 mg/dL), possibly due to altered metabolic clearance or coexisting non-malarial conditions. Blood sugar levels were markedly decreased in infected individuals (85.4,4-Dimethyl-6-ethynylthiochroman supplier 42–73.PMID:34786651 92 mg/dL) versus controls (99.99 mg/dL), indicating hypoglycemia—a known risk factor for severe disease. This was especially evident in P. falciparum cases, where low glucose levels correlated inversely with parasite density (r = –0.308, P = 0.01). Blood urea levels were reduced in all groups (28.88–27.08 mg/dL vs. 34.30 mg/dL in controls), likely due to impaired renal perfusion or catabolic stress.

These findings illustrate that malarial anaemia is multifactorial, driven by haemolysis of parasitized cells, accelerated clearance of uninfected erythrocytes, suppressed erythropoiesis, and inflammatory-mediated suppression of bone marrow function. The strong association between ESR, bilirubin, and parasite load underscores the role of systemic inflammation in disease progression. Furthermore, the differential impact on renal function and metabolism highlights species-specific pathophysiological mechanisms.

In conclusion, this study confirms that haematological parameters are not merely indicators of infection but active participants in the disease process. Their integration into clinical assessment enables early recognition of severe disease, guides therapeutic decisions, and improves outcomes. Monitoring these markers can help identify patients at risk of complications such as acute kidney injury, severe anaemia, or metabolic instability—particularly in vulnerable populations. Thus, routine haematological screening should be prioritized in malaria-endemic areas as a cornerstone of effective, timely, and life-saving management.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com